XML 57 R40.htm IDEA: XBRL DOCUMENT v3.6.0.2
Stockholders' Equity (Tables)
 12 Months Ended
Dec. 31, 2016
Stockholders' Equity Attributable to Parent [Abstract]  
Schedule of Stock by Class
Changes in common shares and treasury stock were as follows:
(MILLIONS OF SHARES)
 
Common Shares Issued(a)

 
Treasury Stock(a)

Balance, December 31, 2013
 
500.01

 
—

Stock-based compensation(b)
 
0.10

 
0.01

Defined contribution plan
 
1.23

 
—

Balance, December 31, 2014
 
501.34

 
0.01

Stock-based compensation(b)
 
0.47

 
0.06

Share repurchase program(c)
 
—

 
4.34

Balance, December 31, 2015
 
501.81

 
4.41

Stock-based compensation(b)
 
0.08

 
(1.72
)
Share repurchase program(c)
 
—

 
6.34

Balance, December 31, 2016
 
501.89

 
9.04


(a) 
Shares may not add due to rounding.
(b) 
Includes the issuance of shares of common stock and, beginning in the first quarter of 2016, the reissuance of shares from treasury stock in connection with the vesting of employee share-based awards. Treasury stock also includes the reacquisition of shares associated with the vesting of employee share-based awards to satisfy tax withholding requirements. For additional information regarding share-based compensation, see Note 14. Share-Based Payments.
(c) 
In November 2014, the company's Board of Directors authorized a $500 million share repurchase program. This program was substantially completed as of December 31, 2016. There were no share repurchases under this program during the year ended December 31, 2014.
In December 2016, the company's Board of Directors authorized an additional $1.5 billion share repurchase program. There were no share repurchases under this program as of December 31, 2016.
Purchases of Zoetis shares may be made at the discretion of management, depending on market conditions and business needs.
Schedule of Accumulated Other Comprehensive Income (Loss)
Changes, net of tax, in accumulated other comprehensive loss, excluding noncontrolling interest, follow:
 
 
 
 
Currency Translation

 
 
 
Accumulated

 
 
Derivatives

 
Adjustment

 
Benefit Plans

 
Other

 
 
Net Unrealized

 
Net Unrealized

 
Actuarial

 
Comprehensive

(MILLIONS OF DOLLARS)
 
(Losses)/Gains

 
(Losses)/Gains

 
Gains/(Losses)

 
(Loss)/Income

Balance, December 31, 2013
 
$
—

 
$
(212
)
 
$
(7
)
 
$
(219
)
Other comprehensive loss, net of tax
 
—

 
(124
)
 
(7
)
(a) 
(131
)
Pension plan transfers from Pfizer Inc.(b)
 
—

 
—

 
(11
)
 
(11
)
Balance, December 31, 2014
 
—

 
(336
)
 
(25
)
 
(361
)
Other comprehensive (loss)/gain, net of tax
 
(2
)
 
(268
)
 
9

 
(261
)
Balance, December 31, 2015
 
(2
)
 
(604
)
 
(16
)
 
(622
)
Other comprehensive gain/(loss), net of tax
 
10

 
19

 
(7
)

22

Divestiture of noncontrolling interest(c)
 
$
—

 
$
2

 
$
—

 
$
2

Balance, December 31, 2016
 
$
8

 
$
(583
)
 
$
(23
)
 
$
(598
)

(a)
Includes the 2014 settlement charge associated with the 2012 sale of our Netherlands manufacturing facility. See Note 13. Benefit Plans.
(b)
Relates to transfers of defined benefit pension plans from Pfizer Inc. and the reclassification from Additional Paid in Capital to Accumulated Other Comprehensive Loss. See Note 13. Benefit Plans.
(c) 
Reflects the divestiture of our share of our Taiwan joint venture. See Note 4B. Acquisitions, Divestitures and Certain Investments: Divestitures.